Wednesday, 03 July 2024


Takeda invests $14 M to expand first ‘Zero Carbon Emissions’ biotech unit in Singapore

24 September 2021 | News

$14 million expansion- first of its kind in biotechnology industry in Singapore

Takeda Pharmaceutical building is preparing to follow the Singapore Green Mark Zero Energy certification scheme first within the company’s global manufacturing and supply network.

Takida is injecting $14 million in the expansion of manufacturing operations in Singapore. The endeavor is the first ‘net zero carbon emissions’ building in its global network and a first-of-its-kind investment within the biotechnology industry in Singapore. 

Singapore’s Minister for Trade and Industry (MTI) Mr. Gan Kim Yong, His Excellency Jun Yamazaki, the Japanese Ambassador to Singapore, Tan Kong Hwee, Executive Vice President of the Singapore Economic Development Board (EDB), Alvin Tan, Assistant CEO of Industry Cluster Group of JTC, and other partners and guests graced the groundbreaking ceremony. 

Located next to Takeda’s biologics manufacturing plant in JTC’s 60-hectare Woodlands Wafer Fab Park, Takeda’s new zero energy building is planned for occupancy by 2022.

The building follows standards from the Singapore Building Construction Authority’s (BCA) Green Mark (GM) certification scheme and sets the bar for green energy design. The approval processes include the design, piling, construction, occupation and completion phases. The 60-hectare Woodlands Wafer Fab Park caters to the stringent operating requirements of the global semiconductor and biomedical firms.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account